There are currently 29 active clinical trials seeking participants for Idiopathic Pulmonary Fibrosis research studies. The states with the highest number of trials for Idiopathic Pulmonary Fibrosis participants are California, Florida, Texas and Pennsylvania.
IPF mHealth Exercise
NCT04838275
Recruiting
Patients with idiopathic pulmonary fibrosis (IPF) who are stable on antifibrotic therapy at least 3 months will be randomized to complete a 12-week home exercise intervention using an mHealth platform, plus a pre- and post-intervention monitoring period (4 weeks each) and in-person study assessments.
Gender:
All
Ages:
Between 40 years and 80 years
Trial Updated:
05/10/2023
Locations: University of Washington, Seattle, Washington
Conditions: Idiopathic Pulmonary Fibrosis
Register for Updates
Effect of CPAP on Abnormal Gastroesophageal Reflux and Lung Inflammation in IPF
NCT05359965
Recruiting
This study will evaluate the effect of CPAP therapy on esophageal pH and lung inflammation in patients with idiopathic pulmonary fibrosis (IPF) and sleep apnea.
Gender:
All
Ages:
50 years and above
Trial Updated:
04/24/2023
Locations: University of Arizona, Tucson, Arizona
Conditions: Idiopathic Pulmonary Fibrosis, Obstructive Sleep Apnea, Gastro Esophageal Reflux
Register for Updates
Atezolizumab for Idiopathic Pulmonary Fibrosis
NCT05515627
Recruiting
The purpose of this study is to determine the safety and preliminary efficacy of atezolizumab, an immune checkpoint inhibitor approved for the treatment of various cancers, in patients with idiopathic pulmonary fibrosis (IPF).
Gender:
All
Ages:
Between 50 years and 80 years
Trial Updated:
01/19/2023
Locations: Cedars-Sinai Medical Center, Los Angeles, California
Conditions: Idiopathic Pulmonary Fibrosis
Register for Updates
Pulmonary Fibrosis Foundation Community Registry
NCT05382572
Recruiting
Pulmonary fibrosis (PF) results from a diverse group of health conditions and affects the lives of patients (including those who are post lung transplant), caregivers and family members. The Pulmonary Fibrosis Foundation Community Registry will offer an online portal where participants can self-enroll and directly contribute information about their experience with PF to be compiled into a longitudinal data set for use by researchers.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/28/2022
Locations: Pulmonary Fibrosis Foundation, Chicago, Illinois
Conditions: Pulmonary Fibrosis, Interstitial Lung Disease, Lung Fibrosis, Idiopathic Pulmonary Fibrosis
Register for Updates
Role of Genetics in Idiopathic Pulmonary Fibrosis (IPF)
NCT01088217
Recruiting
The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose individuals to develop pulmonary fibrosis. Finding the genes that cause pulmonary fibrosis is the first step at developing better methods for early diagnosis and improved treatment for pulmonary fibrosis. The overall hypothesis is that inherited genetic factors predispose individuals to develop pulmonary fibrosis... Read More
Gender:
All
Ages:
All
Trial Updated:
09/11/2020
Locations: University of Colorado Denver, Aurora, Colorado +3 locations
Conditions: Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis, Idiopathic Interstitial Pneumonia, Familial Interstitial Pneumonia
Register for Updates